EQUINOX NEPREMICNINE d.d. Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	114	114	101	94	90	-
Market Cap Growth	1.20%	13.08%	7.44%	4.88%	-	-
Enterprise Value	126	124	109	99	96	-
Last Close Price	63.50	61.92	53.02	47.81	44.24	-
PE Ratio	39.98	47.96	94.46	108.24	125.98	-
PS Ratio	11.93	12.19	11.66	12.08	12.21	-
PB Ratio	2.99	2.89	2.66	2.36	2.17	-
P/OCF Ratio	14.27	17.17	15.90	16.49	10.82	-
EV/Sales Ratio	13.15	13.27	12.59	12.71	13.06	-
EV/EBITDA Ratio	14.62	20.16	25.72	23.97	19.93	-
EV/EBIT Ratio	39.03	52.67	349.92	269.49	68.35	-
Debt / Equity Ratio	0.31	0.27	0.22	0.22	0.35	0.35
Debt / EBITDA Ratio	1.36	1.71	1.93	2.15	3.03	3.60
Net Debt / Equity Ratio	0.31	0.26	0.21	0.13	0.09	0.18
Net Debt / EBITDA Ratio	1.36	1.69	1.84	1.27	0.79	1.88
Asset Turnover	0.17	0.18	0.17	0.14	0.13	-
Quick Ratio	0.61	0.67	0.98	3.15	1.78	5.39
Current Ratio	0.71	0.67	0.98	3.15	1.78	5.65
Return on Equity (ROE)	7.69%	6.16%	2.75%	2.14%	1.75%	-
Return on Assets (ROA)	3.68%	2.75%	0.37%	0.40%	1.52%	-
Return on Invested Capital (ROIC)	4.77%	3.59%	0.51%	0.63%	2.14%	0.83%
Earnings Yield	2.49%	2.08%	1.06%	0.92%	0.79%	-
Dividend Yield	3.15%	3.23%	3.45%	3.54%	3.23%	-
Payout Ratio	126.03%	137.18%	282.71%	295.15%	-	-
Buyback Yield / Dilution	0.78%	-0.09%	1.51%	-1.73%	-	-
Total Shareholder Return	3.88%	3.14%	4.96%	1.81%	3.23%	-